211 related articles for article (PubMed ID: 12940467)
1. Advances in statistical methods for substance abuse prevention research.
MacKinnon DP; Lockwood CM
Prev Sci; 2003 Sep; 4(3):155-71. PubMed ID: 12940467
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Analysis of mediating variables in prevention and intervention research.
MacKinnon DP
NIDA Res Monogr; 1994; 139():127-53. PubMed ID: 8742555
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Latent class analysis of substance abuse patterns.
Uebersax JS
NIDA Res Monogr; 1994; 142():64-80. PubMed ID: 9243533
[TBL] [Abstract][Full Text] [Related]
6. Advanced Categorical Data Analysis in Prevention Science.
Wiedermann W; Bonifay W; Huang FL
Prev Sci; 2023 Apr; 24(3):393-397. PubMed ID: 36633766
[TBL] [Abstract][Full Text] [Related]
7. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
[TBL] [Abstract][Full Text] [Related]
8. Prevention validation and accounting platform: a framework for establishing accountability and performance measures of substance abuse prevention programs.
Kim S; McLeod JH; Williams C; Hepler N
J Drug Educ; 2000; 30(1):1-143. PubMed ID: 10893910
[TBL] [Abstract][Full Text] [Related]
9. Deployment of personnel to military operations: impact on mental health and social functioning.
Bøg M; Filges T; Jørgensen AMK
Campbell Syst Rev; 2018; 14(1):1-127. PubMed ID: 37131363
[TBL] [Abstract][Full Text] [Related]
10. Issues in classification in meta-analysis in substance abuse prevention research.
Hansen WB; Rose LA
NIDA Res Monogr; 1997; 170():183-201. PubMed ID: 9154258
[No Abstract] [Full Text] [Related]
11. Issues and challenges in coding interventions for meta-analysis of prevention research.
Devine EC
NIDA Res Monogr; 1997; 170():130-46. PubMed ID: 9154255
[No Abstract] [Full Text] [Related]
12. Correction for the design effect in school-based substance use and abuse prevention research: sample size requirements and analysis considerations.
Dielman TE
NIDA Res Monogr; 1994; 139():115-25. PubMed ID: 8742554
[No Abstract] [Full Text] [Related]
13. Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group-based modeling approach.
Xie H; Drake R; McHugo G
Adm Policy Ment Health; 2006 Jul; 33(4):423-32. PubMed ID: 16691463
[TBL] [Abstract][Full Text] [Related]
14. Required sample size to detect mediation in 3-level implementation studies.
Williams NJ; Preacher KJ; Allison PD; Mandell DS; Marcus SC
Implement Sci; 2022 Oct; 17(1):66. PubMed ID: 36183090
[TBL] [Abstract][Full Text] [Related]
15. Universal school-based substance abuse prevention programs: Modeling targeted mediators and outcomes for adolescent cigarette, alcohol and marijuana use.
Stephens PC; Sloboda Z; Stephens RC; Teasdale B; Grey SF; Hawthorne RD; Williams J
Drug Alcohol Depend; 2009 Jun; 102(1-3):19-29. PubMed ID: 19362433
[TBL] [Abstract][Full Text] [Related]
16. The Adolescent Substance Abuse Prevention Study: A randomized field trial of a universal substance abuse prevention program.
Sloboda Z; Stephens RC; Stephens PC; Grey SF; Teasdale B; Hawthorne RD; Williams J; Marquette JF
Drug Alcohol Depend; 2009 Jun; 102(1-3):1-10. PubMed ID: 19332365
[TBL] [Abstract][Full Text] [Related]
17. A comparison of missing data methods for hypothesis tests of the treatment effect in substance abuse clinical trials: a Monte-Carlo simulation study.
Hedden SL; Woolson RF; Malcolm RJ
Subst Abuse Treat Prev Policy; 2008 Jun; 3():13. PubMed ID: 18522752
[TBL] [Abstract][Full Text] [Related]
18. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
[TBL] [Abstract][Full Text] [Related]
19. Multilevel models for hierarchically nested data: potential applications in substance abuse prevention research.
Kreft IG
NIDA Res Monogr; 1994; 142():140-83. PubMed ID: 9243536
[TBL] [Abstract][Full Text] [Related]
20. Benefit-cost analysis of drug abuse prevention programs: a macroscopic approach.
Kim S; Coletti SD; Crutchfield CC; Williams C; Hepler N
J Drug Educ; 1995; 25(2):111-27. PubMed ID: 7658292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
